This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Thomas Helledays Stiftelse for Medicinsk Forskning, Université De Droit Et De La Santé De Lille 2. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Orebro, SE (2015)
- Knivsta, SE (2018 - 2019)
Company Filing History:
2 out of 10 
2 out of 10 Years Active: 2015-2019
Title: Innovations and Contributions of Matthieu Frederik Desroses
Introduction
Matthieu Frederik Desroses is a distinguished inventor based in Knivsta, Sweden. With an impressive portfolio of four patents, Desroses has made significant strides in the fields of medicinal chemistry and pharmacology. His innovative work primarily focuses on compounds that enhance antibiotic efficacy and address various medical conditions, including autoimmune diseases.
Latest Patents
Among Desroses' latest innovations are two noteworthy patents. The first patent pertains to spiroisoxazoline compounds which have the potential to potentiate the activity of antibiotics. This invention specifically targets bacterial and mycobacterial infections, such as tuberculosis, offering a promising avenue for treatment when used in combination with existing antibiotics. The second patent involves MTH1 inhibitors, which are designed for use in treating inflammatory and autoimmune conditions. Both inventions illustrate his dedication to advancing medical science through innovative compounds.
Career Highlights
Throughout his career, Matthieu Frederik Desroses has been associated with esteemed research institutions, most notably the Thomas Helledays Foundation for Medical Research. His contributions in medicinal discoveries have positioned him as a pivotal figure in pharmaceutical innovation. His inventive work has not only expanded the understanding of drug efficacy but has also paved the way for therapeutic advancements aimed at improving patient outcomes.
Collaborations
Collaboration plays a vital role in Desroses' career. He has worked alongside renowned colleagues, including Martin Scobie and Tobias Koolmeister. This collaboration has fostered a creative environment that encourages the exchange of ideas and collective problem-solving, further enhancing the impact of their innovations.
Conclusion
Matthieu Frederik Desroses stands out as an influential inventor whose work is characterized by a commitment to improving healthcare through innovative solutions. His recent patents underscore his role in the ongoing battle against bacterial infections and autoimmune diseases, promising a brighter future for therapeutic developments in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile